Details for New Drug Application (NDA): 020233
✉ Email this page to a colleague
The generic ingredient in RHINOCORT is budesonide. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Summary for 020233
Tradename: | RHINOCORT |
Applicant: | Astrazeneca |
Ingredient: | budesonide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020233
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;NASAL | Strength | 0.032MG/INH | ||||
Approval Date: | Feb 14, 1994 | TE: | RLD: | No |
Complete Access Available with Subscription